Stentless aortic bioprostheses offer potential advantages in terms of durability and hemodynamic performance. The study aim was to evaluate the early postoperative performance of the Sorin Pericarbon stentless bioprosthesis. Methods: Between November 1999 and December 2000, 34 patients (12 males, 22 females; mean age 71.2 ± 4.8 years; range: 48-85 years) underwent aortic valve (AV) replacement with the Sorin Pericarbon stentless bioprosthesis. Twenty-two patients were in NYHA classes III-IV, and 12 were in classes I-II. Twenty-one patients had AV stenosis, nine AV regurgitation, and four mixed pathology. Doppler-echocardiography was performed before surgery, at hospital discharge and at six-month follow up. At this time, 20 patients also underwent echo-Doppler stress testing, with peak transvalvular gradient measured at rest and during exercise. Results: There were two hospital deaths (not valve-related). No significant perioperative complications were recorded. At hospital discharge, the aortic peak gradient was 15.7 ± 10.6 mmHg; nil or trivial aortic regurgitation was found in three patients. During six months follow up no endocarditis or thromboembolic events were registered. At six months postoperatively, the transvalvular peak gradient showed a small but significant decrease (11.3 ± 3.5 mmHg at six months, p = 0.036). Mean left ventricular mass index was also decreased significantly (118.4 ± 28.5 versus 98.4 ± 17.8 g/m2, p = 0.024). Left ventricular ejection fraction and effective orifice area were not changed significantly during follow up. In patients undergoing exercise testing (mean maximal workload 96 ± 48 W), the peak aortic gradient was increased (not significantly) at exercise peak (from 14.7 ± 6.5 to 17.2 ± 6.7 mmHg, p = 0.086). Conclusion: The excellent early postoperative outcome of this experience with the Sorin Pericarbon stentless valve encourages the use of this prosthesis. Long-term follow up and further evaluations are required with regard to hemodynamic performance and durability.

Early postoperative outcome and hemodynamic performance of the Sorin pericarbon stentless aortic valve / M.Bonacchi ; G. Giunti ; G. Prifti ; C. Rostagno; M. Bini ; G. Frati ; G. Sani. - In: JOURNAL OF HEART VALVE DISEASE. - ISSN 0966-8519. - STAMPA. - 11:(2002), pp. 703-709.

Early postoperative outcome and hemodynamic performance of the Sorin pericarbon stentless aortic valve

BONACCHI, MASSIMO;ROSTAGNO, CARLO;SANI, GUIDO
2002

Abstract

Stentless aortic bioprostheses offer potential advantages in terms of durability and hemodynamic performance. The study aim was to evaluate the early postoperative performance of the Sorin Pericarbon stentless bioprosthesis. Methods: Between November 1999 and December 2000, 34 patients (12 males, 22 females; mean age 71.2 ± 4.8 years; range: 48-85 years) underwent aortic valve (AV) replacement with the Sorin Pericarbon stentless bioprosthesis. Twenty-two patients were in NYHA classes III-IV, and 12 were in classes I-II. Twenty-one patients had AV stenosis, nine AV regurgitation, and four mixed pathology. Doppler-echocardiography was performed before surgery, at hospital discharge and at six-month follow up. At this time, 20 patients also underwent echo-Doppler stress testing, with peak transvalvular gradient measured at rest and during exercise. Results: There were two hospital deaths (not valve-related). No significant perioperative complications were recorded. At hospital discharge, the aortic peak gradient was 15.7 ± 10.6 mmHg; nil or trivial aortic regurgitation was found in three patients. During six months follow up no endocarditis or thromboembolic events were registered. At six months postoperatively, the transvalvular peak gradient showed a small but significant decrease (11.3 ± 3.5 mmHg at six months, p = 0.036). Mean left ventricular mass index was also decreased significantly (118.4 ± 28.5 versus 98.4 ± 17.8 g/m2, p = 0.024). Left ventricular ejection fraction and effective orifice area were not changed significantly during follow up. In patients undergoing exercise testing (mean maximal workload 96 ± 48 W), the peak aortic gradient was increased (not significantly) at exercise peak (from 14.7 ± 6.5 to 17.2 ± 6.7 mmHg, p = 0.086). Conclusion: The excellent early postoperative outcome of this experience with the Sorin Pericarbon stentless valve encourages the use of this prosthesis. Long-term follow up and further evaluations are required with regard to hemodynamic performance and durability.
2002
11
703
709
M.Bonacchi ; G. Giunti ; G. Prifti ; C. Rostagno; M. Bini ; G. Frati ; G. Sani
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/397731
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 14
social impact